These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 859560)

  • 21. Tumor-targeting potential of radioiodinated iododeoxyuridine in bladder cancer.
    Van den Abbeele AD; Tutrone RF; Berman RM; Baranowska-Kortylewicz J; Barclay PD; Richie JP; Adelstein SJ; Kassis AI
    J Nucl Med; 1996 Feb; 37(2):315-20. PubMed ID: 8667069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential for tumor therapy with iodine-125 labeled immunoglobulins.
    Adelstein SJ; Kassis AI; Baranowska-Kortylewicz J; van den Abbeele AD; Mariani G; Ito S
    Int J Rad Appl Instrum B; 1991; 18(1):43-4. PubMed ID: 2010304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of accelerated repopulation in normal and malignant squamous epithelia during fractionated radiotherapy.
    Kummermehr J; Dörr W; Trott KR
    BJR Suppl; 1992; 24():193-9. PubMed ID: 1290700
    [No Abstract]   [Full Text] [Related]  

  • 24. Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
    Humm JL; Bagshawe KD; Sharma SK; Boxer G
    Br J Radiol; 1991 Jan; 64(757):45-9. PubMed ID: 1998837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxic and hypoxic cells in a murine squamous cell carcinoma.
    Takai Y; Sakamoto K; Okada S
    Jpn J Cancer Res; 1988 Apr; 79(4):523-8. PubMed ID: 3133341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of combination treatment with cis-platinum and low dose rate 125I radiation in a murine brachytherapy model.
    da Silva V; Gutin PH; Barcellos-Hoff MH; Bernstein MA; Deen DF; Weaver KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1471-2. PubMed ID: 6540767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts.
    Buchegger F; Adamer F; Schaffland AO; Kosinski M; Grannavel C; Dupertuis YM; de Tribolet N; Mach JP; Delaloye AB
    Int J Cancer; 2004 May; 110(1):145-9. PubMed ID: 15054880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anomalous effects of 125I after its incorporation into mammalian cell DNA.
    Painter RB; Young BR
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):472-9. PubMed ID: 565275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site of radiation damage.
    Warters RL; Hofer KG; Harris CR; Smith JM
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):389-407. PubMed ID: 565271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic implications of iodine-125 cytotoxicity.
    Bloomer WD; McLaughlin WH; Adelstein SJ
    Int J Radiat Oncol Biol Phys; 1982 Nov; 8(11):1903-8. PubMed ID: 7153101
    [No Abstract]   [Full Text] [Related]  

  • 31. Radiolabeled nucleoside analogs in cancer diagnosis and therapy.
    Kassis AI; Adelstein SJ; Mariani G
    Q J Nucl Med; 1996 Sep; 40(3):301-19. PubMed ID: 8961807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological consequence of nuclear versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger cascades in vivo.
    Rao DV; Narra VR; Howell RW; Sastry KS
    Radiat Res; 1990 Nov; 124(2):188-93. PubMed ID: 2247599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auger electron emitters: insights gained from in vitro experiments.
    Makrigiorgos G; Adelstein SJ; Kassis AI
    Radiat Environ Biophys; 1990; 29(2):75-91. PubMed ID: 2187215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA uptake of 131I-iododeoxyuridine.
    Baranowska-Kortylewicz J; Nearman J
    J Nucl Med; 2005 May; 46(5):898-9. PubMed ID: 15872365
    [No Abstract]   [Full Text] [Related]  

  • 35. [125I-iododeoxyuridine in the reaction of experimental tumors to irradiation].
    Spryshkova RA; Sevast'ianov AI; Naĭdenov MG; Riabukhin IuS; Serebriakov NG
    Med Radiol (Mosk); 1986 Sep; 31(9):40-5. PubMed ID: 3762350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthermia and radiation--a selective thermal effect on chronically hypoxic tumor cells in vivo.
    Dewey WC; Thrall DE; Gillette EL
    Int J Radiat Oncol Biol Phys; 1977; 2(1-2):99-103. PubMed ID: 849909
    [No Abstract]   [Full Text] [Related]  

  • 37. Estrogen receptor-mediated cytotoxicity using iodine-125.
    Bloomer WD; McLaughlin WH; Milius RA; Weichselbaum RR; Adelstein SJ
    J Cell Biochem; 1983; 21(1):39-45. PubMed ID: 6874726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies for selective targeting of Auger electron emitters to tumor cells.
    O'Donoghue JA
    J Nucl Med; 1996 Apr; 37(4 Suppl):3S-6S. PubMed ID: 8676202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
    Govindan SV; Goldenberg DM; Elsamra SE; Griffiths GL; Ong GL; Brechbiel MW; Burton J; Sgouros G; Mattes MJ
    J Nucl Med; 2000 Dec; 41(12):2089-97. PubMed ID: 11138697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iodine-123-iododeoxyuridine: a potential indicator of tumour response to treatment.
    Robins AB; Taylor DM
    Int J Nucl Med Biol; 1981; 8(1):53-63. PubMed ID: 7228519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.